Wikisage, the free encyclopedia of the second generation, is digital heritage
Aspirin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (→Links) |
||
(One intermediate revision by the same user not shown) | |||
Line 16: | Line 16: | ||
==[[ATC]]== | ==[[ATC]]== | ||
[[File:Under construction icon.png|thumb|left]] | |||
[[File:Aspirin-B-3D-balls.png|thumb]] | [[File:Aspirin-B-3D-balls.png|thumb]] | ||
Salicylic acid and derivates | Salicylic acid and derivates | ||
Line 29: | Line 29: | ||
[[nl:aspirine]] | [[nl:aspirine]] | ||
{{Wikidata|Q18216}} | {{Wikidata|Q18216}} | ||
[[Category:World Health Organization essential medicines]] |
Latest revision as of 01:36, 26 January 2019
Aspirin is an NSAID [1] A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibiting platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin [2]
Kawasaki
Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory to this treatment [3]
Hutchinson-Gilford Progeria
Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications [4]
ATC
Salicylic acid and derivates
- Acetylsalicylic acid (INN)